Please Wait
Applying Filters...
menu
    • menu
    Excipient Market Overview: Clariant sets up its first PEG excipients facility in US; India harmonizes 22 excipient monographs

    DATA COMPILATION
    #PharmaFlow

    Pipeline Prospector March 2026 highlights: Lilly to acquire Centessa for US$ 7.8 bn; Merck buys Terns Pharma for US$ 6.7 bn

    Stock Recap
    #PipelineProspector

    Menu

    Scopolamine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,401Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    31/03/2026 Phytex Australia
    Australia
    		 Alpha Pharma Co., Ltd. 20220506-211-J-1287 scopolamine 2022-05-06 Phytex Australia Pty Ltd Australia 6 Norman Street Peakhurst NSW 2210 Australia
    31/03/2026 Myungmoon Pharm. Co., LTD.
    South Korea
    		 Myeongmun Bio Co., Ltd. 20250421-211-J-1868 scopolamine 2025-04-21 Myeongmun Bio Co., Ltd. @ Australian Alkaloids Pty Ltd South Korea 28, Jeyakgongdan 2-gil, Hyangnam-eup, Hwaseong-si, Gyeonggi-do (Building 10 and others) @ Oilseeds Road Memerambi (Via Kingaroy) QLD 4610, Australia
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.